Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 8 | 2021 | 268 | 2.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2015 | 245 | 1.200 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2021 | 8 | 1.140 |
Why?
|
| Osteoblasts | 3 | 2021 | 99 | 0.890 |
Why?
|
| Osteogenesis | 3 | 2021 | 152 | 0.830 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1034 | 0.770 |
Why?
|
| Cell Lineage | 4 | 2015 | 146 | 0.700 |
Why?
|
| Dental Pulp | 1 | 2018 | 10 | 0.630 |
Why?
|
| Periodontal Ligament | 1 | 2018 | 16 | 0.620 |
Why?
|
| Chondrocytes | 2 | 2015 | 27 | 0.550 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 1033 | 0.460 |
Why?
|
| Osteocytes | 1 | 2012 | 8 | 0.420 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 42 | 0.420 |
Why?
|
| Tibial Fractures | 1 | 2012 | 25 | 0.420 |
Why?
|
| Fracture Healing | 1 | 2012 | 29 | 0.420 |
Why?
|
| T-Lymphocytes | 4 | 2022 | 597 | 0.400 |
Why?
|
| Tibia | 1 | 2012 | 93 | 0.400 |
Why?
|
| Green Fluorescent Proteins | 3 | 2018 | 200 | 0.340 |
Why?
|
| Mice | 8 | 2021 | 8474 | 0.330 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2550 | 0.320 |
Why?
|
| Animals | 11 | 2021 | 20881 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 2791 | 0.240 |
Why?
|
| Fibroblasts | 3 | 2015 | 902 | 0.210 |
Why?
|
| Adipocytes | 2 | 2015 | 88 | 0.210 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 49 | 0.200 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 58 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 756 | 0.190 |
Why?
|
| PPAR gamma | 2 | 2019 | 95 | 0.180 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 22 | 0.170 |
Why?
|
| Thiazolidines | 1 | 2018 | 23 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 95 | 0.160 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 118 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 87 | 0.150 |
Why?
|
| Biphenyl Compounds | 1 | 2018 | 184 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2018 | 87 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 201 | 0.150 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2017 | 24 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 304 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 132 | 0.150 |
Why?
|
| Sphingosine | 1 | 2019 | 315 | 0.150 |
Why?
|
| NAD | 1 | 2017 | 73 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2018 | 2673 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2017 | 215 | 0.130 |
Why?
|
| Myofibroblasts | 1 | 2015 | 60 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2015 | 205 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2013 | 24 | 0.110 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 16 | 0.110 |
Why?
|
| Chondrogenesis | 1 | 2012 | 15 | 0.110 |
Why?
|
| Osteocalcin | 1 | 2012 | 37 | 0.110 |
Why?
|
| Bone Marrow | 1 | 2012 | 168 | 0.100 |
Why?
|
| Humans | 8 | 2022 | 68618 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2010 | 50 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 770 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 101 | 0.090 |
Why?
|
| Superoxides | 1 | 2009 | 70 | 0.080 |
Why?
|
| Epitopes | 1 | 2009 | 146 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 124 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2009 | 79 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 135 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 307 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1593 | 0.070 |
Why?
|
| Neoplasms | 1 | 2017 | 1667 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2006 | 35 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 160 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 100 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1692 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 1851 | 0.060 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 99 | 0.050 |
Why?
|
| Male | 5 | 2019 | 37321 | 0.050 |
Why?
|
| Female | 5 | 2019 | 38074 | 0.050 |
Why?
|
| Autophagy | 1 | 2022 | 208 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 54 | 0.040 |
Why?
|
| Apoptosis | 2 | 2022 | 1641 | 0.040 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2019 | 63 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 20 | 0.040 |
Why?
|
| Antibodies | 1 | 2018 | 241 | 0.040 |
Why?
|
| Glutamine | 1 | 2017 | 45 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2017 | 47 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2017 | 101 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2017 | 116 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 331 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 2689 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 13 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 160 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 6 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2009 | 18 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 24 | 0.020 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2009 | 37 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2009 | 10 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2009 | 29 | 0.020 |
Why?
|
| Perilipin-1 | 1 | 2009 | 6 | 0.020 |
Why?
|
| Fibronectins | 1 | 2010 | 130 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2009 | 25 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2009 | 38 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 30 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 63 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2009 | 49 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 144 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 117 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2009 | 91 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 77 | 0.020 |
Why?
|
| Leptin | 1 | 2009 | 80 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 242 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2009 | 112 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2009 | 175 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 149 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 489 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 329 | 0.020 |
Why?
|
| Actins | 1 | 2009 | 249 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2009 | 202 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 710 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 397 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 630 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1174 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 7029 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 40 | 0.020 |
Why?
|
| Retroviridae | 1 | 2006 | 29 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2006 | 63 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 81 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 362 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 597 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 981 | 0.020 |
Why?
|
| Diet | 1 | 2009 | 514 | 0.020 |
Why?
|
| Melanoma | 1 | 2009 | 335 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2006 | 110 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 782 | 0.010 |
Why?
|
| Antioxidants | 1 | 2006 | 304 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 499 | 0.010 |
Why?
|